Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus
© 2016 Elsevier B.V. Treatment of chronic hepatitis B virus (HBV) infection with lamivudine-monotherapy rapidly selects mutant variants in a high proportion of individuals. Monitoring lamivudine resistance by consensus sequencing is costly and insensitive for detection of minority variants. An oligo...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84962283790&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/41780 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
id |
th-cmuir.6653943832-41780 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-417802017-09-28T04:23:19Z Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus Beck I. Payant R. Ngo-Giang-Huong N. Khamduang W. Laomanit L. Jourdain G. Frenkel L. © 2016 Elsevier B.V. Treatment of chronic hepatitis B virus (HBV) infection with lamivudine-monotherapy rapidly selects mutant variants in a high proportion of individuals. Monitoring lamivudine resistance by consensus sequencing is costly and insensitive for detection of minority variants. An oligonucleotide ligation assay (. OLA) for HBV lamivudine-resistance was developed and compared to consensus sequencing. Both assays detected drug resistance mutations in 35/64 (54.7%) specimens evaluated, and OLA detected minority mutants in an additional six (9.4%). OLA may offer a sensitive and inexpensive alternative to consensus sequencing for detection of HBV drug resistance in resource-limited settings. 2017-09-28T04:23:19Z 2017-09-28T04:23:19Z 2016-07-01 Journal 01660934 2-s2.0-84962283790 10.1016/j.jviromet.2016.03.014 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84962283790&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/41780 |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
country |
Thailand |
collection |
CMU Intellectual Repository |
description |
© 2016 Elsevier B.V. Treatment of chronic hepatitis B virus (HBV) infection with lamivudine-monotherapy rapidly selects mutant variants in a high proportion of individuals. Monitoring lamivudine resistance by consensus sequencing is costly and insensitive for detection of minority variants. An oligonucleotide ligation assay (. OLA) for HBV lamivudine-resistance was developed and compared to consensus sequencing. Both assays detected drug resistance mutations in 35/64 (54.7%) specimens evaluated, and OLA detected minority mutants in an additional six (9.4%). OLA may offer a sensitive and inexpensive alternative to consensus sequencing for detection of HBV drug resistance in resource-limited settings. |
format |
Journal |
author |
Beck I. Payant R. Ngo-Giang-Huong N. Khamduang W. Laomanit L. Jourdain G. Frenkel L. |
spellingShingle |
Beck I. Payant R. Ngo-Giang-Huong N. Khamduang W. Laomanit L. Jourdain G. Frenkel L. Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus |
author_facet |
Beck I. Payant R. Ngo-Giang-Huong N. Khamduang W. Laomanit L. Jourdain G. Frenkel L. |
author_sort |
Beck I. |
title |
Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus |
title_short |
Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus |
title_full |
Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus |
title_fullStr |
Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus |
title_full_unstemmed |
Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus |
title_sort |
development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis b virus |
publishDate |
2017 |
url |
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84962283790&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/41780 |
_version_ |
1681422065541840896 |